Alessandra Castelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alessandra Castelli has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Michela Lizier
IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy
3 shared publications - Anna Villa
San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy
2 shared publications - Francesca Faggioli
Institute of Genetics and Biomedical Research, UoS of Milan, National Research Council
2 shared publications Franco Lucchini
Centro Ricerche Biotecnologiche, Università Cattolica del Sacro Cuore, Cremona 26100, Italy
2 shared publications- Lucia Susani
Istituto di Tecnologie Biomediche, CNR, Milan, Italy
2 shared publications - Marianna Paulis
Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Segrate (MI), Italy
2 shared publications
Latest Publications
- 27 February 2018
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 10 (2) , 213-221
Cell fusion in the liver, revisited
There is wide agreement that cell fusion is a physiological process in cells in mammalian bone, muscle and placenta. In other organs, such as the cerebellum, cell fusion is controversial. The liver contains a considerable number of polyploid cells: They are commonly believed to originate by genome endoreplication, although the contribution of cell fusion to polyploidization has not been excluded. Here, we address the topic of cell fusion in the liver from a historical point of view. We discuss experimental evidence clearly supporting the hypothesis that cell fusion occurs in the liver, specifically when bone marrow cells were injected into mice and shown to rescue genetic hepatic degenerative defects. Those experiments-carried out in the latter half of the last century-were initially interpreted to show "transdifferentiation", but are now believed to demonstrate fusion between donor macrophages and host hepatocytes, raising the possibility that physiologically polyploid cells, such as hepatocytes, could originate, at least partially, through homotypic cell fusion. In support of the homotypic cell fusion hypothesis, we present new data generated using a chimera-based model, a much simpler model than those previously used. Cell fusion as a road to polyploidization in the liver has not been extensively investigated, and its contribution to a variety of conditions, such as viral infections, carcinogenesis and aging, remains unclear.
- 27 February 2018
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 10 (2) , 213-221
Cell fusion in the liver, revisited
There is wide agreement that cell fusion is a physiological process in cells in mammalian bone, muscle and placenta. In other organs, such as the cerebellum, cell fusion is controversial. The liver contains a considerable number of polyploid cells: They are commonly believed to originate by genome endoreplication, although the contribution of cell fusion to polyploidization has not been excluded. Here, we address the topic of cell fusion in the liver from a historical point of view. We discuss experimental evidence clearly supporting the hypothesis that cell fusion occurs in the liver, specifically when bone marrow cells were injected into mice and shown to rescue genetic hepatic degenerative defects. Those experiments-carried out in the latter half of the last century-were initially interpreted to show "transdifferentiation", but are now believed to demonstrate fusion between donor macrophages and host hepatocytes, raising the possibility that physiologically polyploid cells, such as hepatocytes, could originate, at least partially, through homotypic cell fusion. In support of the homotypic cell fusion hypothesis, we present new data generated using a chimera-based model, a much simpler model than those previously used. Cell fusion as a road to polyploidization in the liver has not been extensively investigated, and its contribution to a variety of conditions, such as viral infections, carcinogenesis and aging, remains unclear.
- Open Access
- 17 October 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (34) , 35218-35230
Chromosome transplantation as a novel approach for correcting complex genomic disorders
Chromosome transplantation as a novel approach for correcting complex genomic disorders
- 17 October 2015
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (34) , 35218-35230
Open AccessChromosome transplantation as a novel approach for correcting complex genomic disorders
Chromosome transplantation as a novel approach for correcting complex genomic disorders
- Open Access
- 24 July 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 12327
A pre-screening FISH-based method to detect CRISPR/Cas9 off-targets in mouse embryonic stem cells
The clustered regularly interspaced short palindromic repeat (CRISPR)/associated 9 (Cas9) technology has been recently added to the tools allowing efficient and easy DNA targeting, representing a very promising approach to gene engineering. Using the CRISPR/Cas9 system we have driven the integration of exogenous DNA sequences to the X-linked Hprt gene of mouse embryonic stem cells. We show here that a simple fluorescence in situ hybridization (FISH)-based strategy allows the detection and the frequency evaluation of non-specific integrations of a given plasmid. FISH analysis revealed that these integrations do not match the software predicted off-target loci. We conclude that the frequency of these CRISPR-mediated off-target DNA cuts is negligible, since, due to the occurrence of spontaneous double-strand breaks, we observed more aspecific plasmid integrations than those corresponding to predicted off-target sites.
- 24 July 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 12327
Open AccessA pre-screening FISH-based method to detect CRISPR/Cas9 off-targets in mouse embryonic stem cells
The clustered regularly interspaced short palindromic repeat (CRISPR)/associated 9 (Cas9) technology has been recently added to the tools allowing efficient and easy DNA targeting, representing a very promising approach to gene engineering. Using the CRISPR/Cas9 system we have driven the integration of exogenous DNA sequences to the X-linked Hprt gene of mouse embryonic stem cells. We show here that a simple fluorescence in situ hybridization (FISH)-based strategy allows the detection and the frequency evaluation of non-specific integrations of a given plasmid. FISH analysis revealed that these integrations do not match the software predicted off-target loci. We conclude that the frequency of these CRISPR-mediated off-target DNA cuts is negligible, since, due to the occurrence of spontaneous double-strand breaks, we observed more aspecific plasmid integrations than those corresponding to predicted off-target sites.